1. Vitamin D receptor ligands: the impact of crystal structures
- Author
-
Antonio Mouriño, Ferdinand Molnár, and Carsten Carlberg
- Subjects
Models, Molecular ,Calcitriol ,Stereochemistry ,Context (language use) ,Ligands ,Calcitriol receptor ,Structure-Activity Relationship ,Drug Discovery ,medicine ,Vitamin D and neurology ,Animals ,Humans ,Structure–activity relationship ,Receptor ,Transcription factor ,Pharmacology ,Molecular Structure ,Chemistry ,General Medicine ,Nuclear receptor ,Biochemistry ,Drug Design ,Receptors, Calcitriol ,lipids (amino acids, peptides, and proteins) ,Crystallization ,medicine.drug - Abstract
In the past years, the biologically active form of vitamin D(3), 1α,25-dihydroxyvitamin D(3) (1α,25(OH)(2)D(3)), has received large appreciation due to the broad physiological impact of the hormone and its nuclear receptor, the transcription factor vitamin D receptor (VDR). Recently, the understanding of VDR actions has progressed greatly, due to VDR crystal structures with various ligands.This review will present and discuss new synthetic agonistic and antagonistic 1α,25(OH)(2)D(3) analogs in the context of the recent insights provided by VDR crystal structures.During the last 5 years, a large number of new 1α,25(OH)(2)D(3) analogs, many of which have an interesting functional profile, have been patented. Moreover, for a surprisingly high number of 1α,25(OH)(2)D(3) analogs, the crystal structure data of their complex with the VDR is available. This structural information provides important insight into the functional potential of the VDR ligands and explains their agonistic and antagonistic action. However, so far, only for a few VDR ligands, a rational design, based on crystal structure information, has been applied. The design of future analogs may also take the specificity of co-factor interaction into account, in order to create selective VDR modulators.
- Published
- 2012
- Full Text
- View/download PDF